← Open Payments lookup

ALAN JENSEN: Open Payments

NPI 1053495614 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$362 in 13 payments from 8 companies in 2025. Trend: 2023 $490 · 2024 $470 · 2025 $362

Food & beverage: $362
CompanyPaymentsAmount
Avadel CNS Pharmaceuticals, LLC3$137
ABBVIE INC.3$70
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$40
Axsome Therapeutics, Inc.1$28
Almatica Pharma LLC1$24
Antares Pharma, Inc.1$23
Novo Nordisk Inc1$21
Esperion Therapeutics, Inc.1$20

Products named: LUMRYZ, VRAYLAR, CAPLYTA, Auvelity, LOREEV XR, LINZESS, XYOSTED, Ozempic.

Industry payments across NE — which companies pay providers there.